Position statement: Recommendations on the diagnosis and treatment of Malassezia folliculitis.


Journal

Journal of the European Academy of Dermatology and Venereology : JEADV
ISSN: 1468-3083
Titre abrégé: J Eur Acad Dermatol Venereol
Pays: England
ID NLM: 9216037

Informations de publication

Date de publication:
Jul 2023
Historique:
received: 11 01 2023
accepted: 07 02 2023
medline: 14 6 2023
pubmed: 14 3 2023
entrez: 13 3 2023
Statut: ppublish

Résumé

Malassezia is a lipophilic yeast that is a part of the human mycobiome. Malassezia folliculitis appears when the benign colonization of the hair follicles, by the Malassezia yeasts, becomes symptomatic with pruritic papules and pustules. Although Malassezia folliculitis is common in hospital departments, diagnosing and treating it varies among dermatologists and countries. The European Academy of Dermatology and Venereology Mycology Task Force Malassezia folliculitis working group has, therefore, sought to develop these recommendations for the diagnosis and management of Malassezia folliculitis. Recommendations comprise methods for diagnosing Malassezia folliculitis, required positive findings before starting therapies and specific treatment algorithms for individuals who are immunocompetent, immunocompromised or who have compromised liver function. In conclusion, this study provides a clinical strategy for diagnosing and managing Malassezia folliculitis.

Identifiants

pubmed: 36912427
doi: 10.1111/jdv.18982
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1268-1275

Subventions

Organisme : LEO Fondet
ID : LF18002

Informations de copyright

© 2023 European Academy of Dermatology and Venereology.

Références

Rubenstein RM, Malerich SA. Malassezia (pityrosporum) folliculitis. J Clin Aesthet Dermatol. 2014;7:37-41.
Sparber F, LeibundGut-Landmann S. Host responses to Malassezia spp. in the mammalian skin. Front Immunol. 2017;8:1614.
Lorch JM, Palmer JM, Vanderwolf KJ, Schmidt KZ, Verant ML, Weller TJ, et al. Malassezia vespertilionis sp. nov.: a new cold-tolerant species of yeast isolated from bats. Persoonia. 2018;41:56-70.
Wang K, Cheng L, Li W, Jiang H, Zhang X, Liu S, et al. Susceptibilities of Malassezia strains from pityriasis versicolor, Malassezia folliculitis and seborrheic dermatitis to antifungal drugs. Heliyon. 2020;6:e04203.
Li W, Zhang ZW, Luo Y, Liang N, Pi XX, Fan YM. Molecular epidemiology, in vitro susceptibility and exoenzyme screening of Malassezia clinical isolates. J Med Microbiol. 2020;69:436-42.
Vlachos C, Henning M, Gaitanis G, Faergemann J, Saunte DM. Critical synthesis of available data in Malassezia folliculitis and a systematic review of treatments. J Eur Acad Dermatol Venereol. 2020;34:1672-83.
Durdu M, Guran M, Ilkit M. Epidemiological characteristics of Malassezia folliculitis and use of the may-Grunwald-Giemsa stain to diagnose the infection. Diagn Microbiol Infect Dis. 2013;76:450-7.
Jacinto-Jamora S, Tamesis J, Katigbak ML. Pityrosporum folliculitis in The Philippines: diagnosis, prevalence, and management. J Am Acad Dermatol. 1991;24:693-6.
Yong AM, Tan SY, Tan CL. An update on pityrosporum folliculitis in Singapore from a single tertiary care dermatological Centre. Singapore Med J. 2021;62:526-528.
Bulmer GS, Pu XM, Yi LXT. Malassezia folliculitis in China. Mycopathologia. 2008;165:411-2.
Abdel-Razek M, Fadaly G, Abdel-Raheim M, al-Morsy F. Pityrosporum (Malassezia) folliculitis in Saudi Arabia--diagnosis and therapeutic trials. Clin Exp Dermatol. 1995;20:406-9.
Gupta AK, Batra R, Bluhm R, Boekhout T, Dawson TL Jr. Skin diseases associated with Malassezia species. J Am Acad Dermatol. 2004;51:785-98.
An MK, Hong EH, Cho EB, Park EJ, Kim KH, Kim KJ. Clinicopathological differentiation between Pityrosporum folliculitis and acneiform eruption. J Dermatol. 2019;46:978-84.
Stulberg DL, Penrod MA, Blatny RA. Common bacterial skin infections. Am Fam Physician. 2002;66:119-24.
Long H, Zhang G, Wang L, Lu Q. Eosinophilic skin diseases: a comprehensive review. Clin Rev Allergy Immunol. 2016;50:189-213.
Saunte DML, Piraccini BM, Sergeev AY, Prohić A, Sigurgeirsson B, Rodríguez-Cerdeira C, et al. A survey among dermatologists: diagnostics of superficial fungal infections - what is used and what is needed to initiate therapy and assess efficacy? J Eur Acad Dermatol Venereol. 2019;33:421-7.
Hald M, Arendrup MC, Svejgaard EL, Lindskov R, Foged EK, Saunte DM. Evidence-based Danish guidelines for the treatment of Malassezia-related skin diseases. Acta Derm Venereol. 2015;95:12-9.
Lortholary O, Petrikkos G, Akova M, Arendrup MC, Arikan-Akdagli S, Bassetti M, et al. ESCMID* *This guideline was presented in part at ECCMID 2011. European Society for Clinical Microbiology and Infectious Diseases. Guideline for the diagnosis and management of Candida diseases 2012: patients with HIV infection or AIDS. Clin Microbiol Infect. 2012;18:68-77.
Cafarchia C, Gasser RB, Figueredo LA, Latrofa MS, Otranto D. Advances in the identification of Malassezia. Mol Cell Probes. 2011;25:1-7.
Tu WT, Chin SY, Chou CL, Hsu CY, Chen YT, Liu D, et al. Utility of gram staining for diagnosis of Malassezia folliculitis. J Dermatol. 2018;45:228-31.
Park HR, Oh JH, Lee YJ, et al. Inflammasome-mediated inflammation by Malassezia in human keratinocytes: a comparative analysis with different strains. Mycoses. 2021;64:292-299.
Velegraki A, Cafarchia C, Gaitanis G, Iatta R, Boekhout T. Malassezia infections in humans and animals: pathophysiology, detection, and treatment. PLoS Pathog. 2015;11:e1004523.
Honnavar P, Ghosh AK, Paul S, Shankarnarayan SA, Singh P, Dogra S, et al. Identification of Malassezia species by MALDI-TOF MS after expansion of database. Diagn Microbiol Infect Dis. 2018;92:118-23.
Denis J, Machouart M, Morio F, Sabou M, Kauffmann-LaCroix C, Contet-Audonneau N, et al. Performance of matrix-assisted laser desorption ionization-time of flight mass spectrometry for identifying clinical Malassezia isolates. J Clin Microbiol. 2016;55:90-6.
Saunte DML, Gaitanis G, Hay RJ. Malassezia-associated skin diseases, the use of diagnostics and treatment. Front Cell Infect Microbiol. 2020;10:112.
Balkis MM, Leidich SD, Mukherjee PK, Ghannoum MA. Mechanisms of fungal resistance: an overview. Drugs. 2002;62:1025-40.
Gupta LK, Singhi MK. Wood's lamp. Indian J Dermatol Venereol Leprol. 2004;70:131-5.
Prindaville B, Belazarian L, Levin NA, Wiss K. Pityrosporum folliculitis: a retrospective review of 110 cases. J Am Acad Dermatol. 2018;78:511-4.
Back O, Faergemann J, Hornqvist R. Pityrosporum folliculitis: a common disease of the young and middle-aged. J Am Acad Dermatol. 1985;12:56-61.
Pürnak S, Durdu M, Tekindal MA, Güleç AT, Seçkin D. The prevalence of Malassezia folliculitis in patients with papulopustular/Comedonal acne, and their response to antifungal treatment. Skinmed. 2018;16:99-104.
Lee JD, Yi JY, Kim SY, Cho BK, Houh W. Pityrosporum folliculitis - clinical and histopathological observation. Annals Dermatol. 1990;2:83-8.
Levy A, Feuilhade de Chauvin M, Dubertret L, Morel P, Flageul B. Malassezia folliculitis: characteristics and therapeutic response in 26 patients. Ann Dermatol Venereol. 2007;134:823-8.
Suzuki C, Hase M, Shimoyama H, Sei Y. Treatment outcomes for Malassezia folliculitis in the dermatology Department of a University Hospital in Japan. Med Mycol J. 2016;57:E63-6.
Tsai YC, Wang JY, Wu YH, Wang YJ. Clinical differences in pediatric and adult Malassezia folliculitis: retrospective analysis of 321 cases over 9 years. J Am Acad Dermatol. 2019;81:278-80.
Bufill JA, Lum LG, Caya JG, Chitambar CR, Ritch PS, Anderson T, et al. Pityrosporum folliculitis after bone marrow transplantation. Clinical observations in five patients. Ann Intern Med. 1988;108:560-3.
Rhie S, Turcios R, Buckley H, Suh B. Clinical features and treatment of Malassezia folliculitis with fluconazole in orthotopic heart transplant recipients. J Heart Lung Transplant. 2000;19:215-9.
Ayers K, Sweeney SM, Wiss K. Pityrosporum folliculitis: diagnosis and management in 6 female adolescents with acne vulgaris. Arch Pediatr Adolesc Med. 2005;159:64-7.
Friedman SJ. Pityrosporum folliculitis: treatment with isotretinoin. J Am Acad Dermatol. 1987;16:632-3.
Goodfield MJ, Saihan EM. Failure of isotretinoin therapy in Pityrosporum folliculitis. J Am Acad Dermatol. 1988;18:143-4.
Lee JW, Kim BJ, Kim MN. Photodynamic therapy: new treatment for recalcitrant Malassezia folliculitis. Lasers Surg Med. 2010;42:192-6.
Kavanagh GM, Leeming JP, Marshman GM, Reynolds NJ, Burton JL. Folliculitis in Down's syndrome. Br J Dermatol. 1993;129:696-9.
Shekelle PG, Woolf SH, Eccles M, Grimshaw J. Clinical guidelines: developing guidelines. Bmj. 1999;318:593-6.

Auteurs

M A S Henning (MAS)

Department of Dermatology, Zealand University Hospital, Roskilde, Denmark.
Department of Clinical Medicine, Health Sciences Faculty, University of Copenhagen, Copenhagen, Denmark.

R Hay (R)

King's College London, London, UK.

C Rodriguez-Cerdeira (C)

Department of Dermatology, Vithas hospital and University of Vigo, Vigo, Spain.

J C Szepietowski (JC)

Department of Dermatology, Venereology and Allergology, Wroclaw Medical University, Wroclaw, Poland.

B M Piraccini (BM)

Dermatology, IRCCS Policlinico di Sant'Orsola, Bologna, Italy.
Department of Experimental, Diagnostic and Specialty Medicine (DIMES), Alma Mater Studiorum University of Bologna, Bologna, Italy.

M P Ferreirós (MP)

Department of Dermatology, Faculty of Medicine, University of Santiago de Compostela, A Coruña, Spain.

M Arabatzis (M)

Dermatology Department, Medical School, University of Thessaloniki, Thessaloniki, Greece.

A Sergeev (A)

All-Russian National Academy of Mycology, Moscow, Russia.

P Nenoff (P)

Laboratory of Medical Microbiology, Mölbis, Germany.

L Kotrekhova (L)

Department of Dermatovenereology, North Western State Medical University, Saint Petersburg, Russia.

R J Nowicki (RJ)

Department of Dermatology, Venereology, and Allergology, Medical University of Gdansk, Gdańsk, Poland.

J Faergemann (J)

Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.

V Padovese (V)

Department of Dermatology and Venereology, Genitourinary Clinic, Mater Dei Hospital, Msida, Malta.
International Foundation for Dermatology, Migrants Health Dermatology Working Group, London, UK.

A Prohic (A)

Department of Dermatovenereology, University Sarajevo School of Science and Technology, Sarajevo Medical School, Sarajevo, Bosnia and Herzegovina.

M Skerlev (M)

Department of Dermatology and Venereology, Zagreb University School of Medicine and Zagreb University Hospital, Zagreb, Croatia.

P Schmid-Grendelmeier (P)

Allergy Unit, Department of Dermatology, University Hospital Zurich and Medical Faculty, University of Zurich, Zurich, Switzerland.

B Sigurgeirsson (B)

Department of Dermatology, Faculty of Medicine, University of Iceland, Reykjavik, Iceland.

G Gaitanis (G)

Department of Skin and Venereal Diseases, Faculty of Medicine, School of Health Sciences, University of Ioannina, Ioannina, Greece.

P Lecerf (P)

Department of Dermatology, University Hospital Brugmann & Saint-Pierre, Université Libre de Bruxelles, Brussels, Belgium.

D M L Saunte (DML)

Department of Dermatology, Zealand University Hospital, Roskilde, Denmark.
Department of Clinical Medicine, Health Sciences Faculty, University of Copenhagen, Copenhagen, Denmark.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH